In Policy Context, Italy’s score is well above the average, having the highest alignment of national care guidelines with international guidelines and the existence of a severe asthma registry being undermined by a limited asthma strategy, the lack of severe asthma guidelines, and limited tobacco control policies. Italy scores within the top third of countries in Access and Care Coverage with a higher-than-average score. This is due to an above-average level of access to treatments (including biologics), access to inflammatory phenotyping-based diagnostics, and high levels of access to telemedicine and remote care. Italy ranks highest in terms of Environmental Factors and is among the top scorers in terms of Disease Burden, with positive, though improvable, performance in the estimated societal cost of severe asthma, asthma DALYs, percentage of deaths attributable to asthma and adult obesity rate.
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Italy
Provides further insights into how Italy scores across each Index category
Guidelines, strategies, and policies related to the management of severe asthma and health outcomes
Regulations and practices concerning public payor coverage for and availability of diagnostic and treatment services for severe asthma
Indicators related to clinical management and economic impact of severe asthma and recording of patient health data
Information about the health impact of severe asthma and severe asthma comorbidities
Factors impacting prevention, management, and exacerbations of severe asthma
Aggregate score across the 5 categories.
Explore how each of the 29 OECD countries scored in the Severe Asthma Index
Select different countries to see how they scored across each of the 5 categories and overall